A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer’s disease
Objective: Amyloid 1-42 (Aβ42) and tau in cerebrospinal fluid are currently used as markers for diagnosis of Alzheimer’s disease. Conflicting reports exist regarding their plasma levels in Alzheimer’s disease patients. A meta-analysis was performed to statistically validate the use of plasma Aβ42 an...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2015-08-01
|
| Series: | SAGE Open Medicine |
| Online Access: | https://doi.org/10.1177/2050312115598250 |
| _version_ | 1819066220010274816 |
|---|---|
| author | Keerthanaa Balasubramanian Shanthi Sreeram Krishnan P Rani |
| author_facet | Keerthanaa Balasubramanian Shanthi Sreeram Krishnan P Rani |
| author_sort | Keerthanaa Balasubramanian Shanthi |
| collection | DOAJ |
| description | Objective: Amyloid 1-42 (Aβ42) and tau in cerebrospinal fluid are currently used as markers for diagnosis of Alzheimer’s disease. Conflicting reports exist regarding their plasma levels in Alzheimer’s disease patients. A meta-analysis was performed to statistically validate the use of plasma Aβ42 and tau as biomarkers for Alzheimer’s disease. Methods: Different databases were searched using the search key: (amyloid OR amyloid1-42 OR Aβ42) AND (tau OR total tau) AND plasma AND (alzheimer’s OR alzheimer’s disease), and for databases not accepting boolean search, records were retrieved using the search key: plasma + amyloid + tau + alzheimer’s. A total of 1880 articles for Aβ42 and 1508 articles for tau were shortlisted. The abstracts were screened, and 69 articles reporting plasma Aβ42 levels and 6 articles reporting plasma tau were identified. After exclusion, 25 studies reporting plasma Aβ42 and 6 studies reporting total tau were analysed in Review Manager version 5.2 using weighted mean difference method, and the bias between studies was assessed using the funnel plot. Results: Plasma Aβ42 and tau did not vary significantly between Alzheimer’s disease patients and controls. The funnel plot showed that there was no bias between studies for Aβ42, while possible bias existed for tau due to availability of limited studies. Conclusion: This analysis pinpoints that plasma Aβ42 and tau could not serve as reliable markers independently for diagnosis of Alzheimer’s disease and a cohort study with age, sex and apolipoprotein E correction is warranted for their possible use as Alzheimer’s disease markers. |
| first_indexed | 2024-12-21T15:58:53Z |
| format | Article |
| id | doaj.art-097108512b0240529a1b427db4d493cb |
| institution | Directory Open Access Journal |
| issn | 2050-3121 |
| language | English |
| last_indexed | 2024-12-21T15:58:53Z |
| publishDate | 2015-08-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | SAGE Open Medicine |
| spelling | doaj.art-097108512b0240529a1b427db4d493cb2022-12-21T18:58:02ZengSAGE PublishingSAGE Open Medicine2050-31212015-08-01310.1177/205031211559825010.1177_2050312115598250A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer’s diseaseKeerthanaa Balasubramanian ShanthiSreeram KrishnanP RaniObjective: Amyloid 1-42 (Aβ42) and tau in cerebrospinal fluid are currently used as markers for diagnosis of Alzheimer’s disease. Conflicting reports exist regarding their plasma levels in Alzheimer’s disease patients. A meta-analysis was performed to statistically validate the use of plasma Aβ42 and tau as biomarkers for Alzheimer’s disease. Methods: Different databases were searched using the search key: (amyloid OR amyloid1-42 OR Aβ42) AND (tau OR total tau) AND plasma AND (alzheimer’s OR alzheimer’s disease), and for databases not accepting boolean search, records were retrieved using the search key: plasma + amyloid + tau + alzheimer’s. A total of 1880 articles for Aβ42 and 1508 articles for tau were shortlisted. The abstracts were screened, and 69 articles reporting plasma Aβ42 levels and 6 articles reporting plasma tau were identified. After exclusion, 25 studies reporting plasma Aβ42 and 6 studies reporting total tau were analysed in Review Manager version 5.2 using weighted mean difference method, and the bias between studies was assessed using the funnel plot. Results: Plasma Aβ42 and tau did not vary significantly between Alzheimer’s disease patients and controls. The funnel plot showed that there was no bias between studies for Aβ42, while possible bias existed for tau due to availability of limited studies. Conclusion: This analysis pinpoints that plasma Aβ42 and tau could not serve as reliable markers independently for diagnosis of Alzheimer’s disease and a cohort study with age, sex and apolipoprotein E correction is warranted for their possible use as Alzheimer’s disease markers.https://doi.org/10.1177/2050312115598250 |
| spellingShingle | Keerthanaa Balasubramanian Shanthi Sreeram Krishnan P Rani A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer’s disease SAGE Open Medicine |
| title | A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer’s disease |
| title_full | A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer’s disease |
| title_fullStr | A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer’s disease |
| title_full_unstemmed | A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer’s disease |
| title_short | A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer’s disease |
| title_sort | systematic review and meta analysis of plasma amyloid 1 42 and tau as biomarkers for alzheimer s disease |
| url | https://doi.org/10.1177/2050312115598250 |
| work_keys_str_mv | AT keerthanaabalasubramanianshanthi asystematicreviewandmetaanalysisofplasmaamyloid142andtauasbiomarkersforalzheimersdisease AT sreeramkrishnan asystematicreviewandmetaanalysisofplasmaamyloid142andtauasbiomarkersforalzheimersdisease AT prani asystematicreviewandmetaanalysisofplasmaamyloid142andtauasbiomarkersforalzheimersdisease AT keerthanaabalasubramanianshanthi systematicreviewandmetaanalysisofplasmaamyloid142andtauasbiomarkersforalzheimersdisease AT sreeramkrishnan systematicreviewandmetaanalysisofplasmaamyloid142andtauasbiomarkersforalzheimersdisease AT prani systematicreviewandmetaanalysisofplasmaamyloid142andtauasbiomarkersforalzheimersdisease |